|
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
|
Paclitaxel/Radiotherapy/Cisplatino for cervical cancer |
|
Phase I with CIGB-814 in rheumatoid arthritis patients |
|
CENTAURO-6 Study |
|
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |
|
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
|
Phase I/II trial with the mutein no alfa of IL-2 |
|
NeuroEPO in patients with Parkinson disease stage II-III |
|
NeuroEPO in patients with Mild-Moderate Alzheimer's disease |
|
Pharmacovigilance-VALERGEN-Asthma |
|
ESAR-814 Study |
|
HEBERFERON in renal cell carcinoma |
|
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain |
|
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
|
Homeostec for the treatment of chronic Chikungunya |
|
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus |
|
NGcGM3/VSSP in small cell lung cancer |
|
NGcGM3/VSSP in Metastatic melanoma |
|
Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months. |
|
Abexol and Atorvastatin in the non alcoholic steatohepatitis |
